Administering Supplemental Iron and Erythropoiesis-Stimulating Agents to Infants Born Preterm: What Do We Need to Build Consensus?

J Pediatr. 2025 Jan 2:114460. doi: 10.1016/j.jpeds.2024.114460. Online ahead of print.

Authors

Robert D Christensen¹, Timothy M Bahr², Robin K Ohls²

Affiliations

¹ From the Division of Neonatology, Department of Pediatrics, University of Utah Health, and Women and Newborn Research, Intermountain Health, Salt Lake City, Utah, USA. Electronic address: robert.christensen@hsc.utah.edu.
² From the Division of Neonatology, Department of Pediatrics, University of Utah Health, and Women and Newborn Research, Intermountain Health, Salt Lake City, Utah, USA.

PMID: 39755234
DOI: 10.1016/j.jpeds.2024.114460

No abstract available

Keywords: darbepoetin; erythropoietin; iron; preterm infant; red blood cell; transfusion.

Publication types

Editorial